Monday, August 31, 2026

SNDL Inc. Stock Soars 22% In 10 Sessions: Is It Worth Investing?

ViaNews Editorial Team

September 8, 2023

SNDL Inc. Stock Soars 22% In 10 Sessions: Is It Worth Investing?

(VIANEWS) - Shares of SNDL Inc. (NASDAQ:SNDL) rose 22.58% over 10 sessions, from EUR1.55 on August 24th to EUR1.90 at 09:40 EST on Friday morning - an upward trend that followed previous session gains. Even as the overall decline of the NASDAQ dropped 0.89% to EUR13,748.83, SNDL Inc. outshone it and closed at EUR1.88, 44.05% below their 52-week high of EUR3.36.

About SNDL Inc.

SNDL Inc. of Canada operates in the cannabis industry, offering products for adult-use and medical markets. Their business segments include Liquor Retail, Cannabis Retail, Operations and Investments - they specialize in cultivating, distributing and selling various brands such as Top Leaf, Sundial Cannabis Palmetto Grasslands etc. Furthermore, SNDL operates wholly-owned retail cannabis stores for private sales of recreational cannabis, produces inhalable products such as flower pre-rolls vapes with headquarters located in Calgary Canada. Established as Sundial Growers Inc. in 2006 they cultivate, distributes and sell various cannabis products under various brands eg. Top Leaf Sundial Cannabis Palmetto Grasslands etc SNDL cultivates, distributes and sells them under various brands including Top Leaf Sundial Cannabis Palmetto Grasslands etc SNDL was previously known as Sundial Growers Inc. with headquarters located there as well.

Yearly Analysis

SNDL Inc. (SNDL), a Canadian cannabis company focused on production and distribution of cannabis products, currently trades at EUR1.90 as of 09:43 EST; this figure is significantly below its 52-week high of EUR3.36 while above its low point of EUR1.25. Investment outlook of SNDL's anticipated sales growth is quite encouraging, with forecasted annual rates of 1185% this year and 32.5% projected for 2019. This increase may be driven by increasing cannabis product demand as well as expanding product offerings and distribution networks. Notably, SNDL's EBITDA stands at 0.41; this indicates the company is currently operating at a loss and could cause some investors to have concerns. Furthermore, cannabis regulations remain highly regulated, which could have an effect on operations and profitability at SNDL. Overall, while SNDL's sales growth projections may seem promising to investors, they should carefully examine its current financial performance and regulatory risks prior to making investment decisions. Furthermore, investors may wish to keep an eye on SNDL's progress toward profitability as well as any changes that occur within its regulatory environment.

Technical Analysis

SNDL Inc. has experienced a recent surge in its stock prices, with current values substantially exceeding both its 50-day and 200-day moving averages. This surge is evidenced in an increasing trading volume - currently 33.42% above its average volume of 3786500. Volatility for this stock has also increased, with intraday variation averages for the past week, month, and quarter ranging between 2.35%, 0.59%, and 3.93% respectively. Furthermore, its highest amplitude recorded over this timeframe being 5.61% for one week's variation alone (4.80% month variation; and 3.933% quarter variation). Based on the stochastic oscillator, SNDL Inc. stock is currently considered overbought with an oscillator value of 80 or higher; this suggests it may be time for a price correction in the near future. Overall, current trends in SNDL Inc. stock prices and volatility suggest that it is currently experiencing a bullish period; however, investors should remain mindful that its overbought condition could prompt a price correction in the near future.

Quarter Analysis

Investment Outlook SNDL Inc. has seen exponential sales and revenue growth. Their current quarter sales increase of 971.6% is particularly notable, suggesting strong consumer interest in their products or services. It is essential that this expansion remains sustainable over time. Year-on-year quarterly revenue growth of 9.3% over the trailing twelve months indicates steady increase in revenue for the company, perhaps attributable to factors such as increased sales or prices or an expanding customer base. Investors should carefully evaluate a company's fundamentals before making any investment decisions, including its financial performance, competitive position and growth prospects. Tracking sales and revenue growth over time may also give an investor insight into its long-term potential.

Equity Analysis

Based on available information, SNDL Inc. has posted a trailing twelve month earnings per share loss of -EUR1.02, signifying that they have experienced losses over the last year. Furthermore, the company's return on equity for the twelve trailing months stands at negative -22.42% indicating that it has failed to generate returns for shareholders relative to their equity investment. Overall, these financial metrics suggest that SNDL Inc. has not generated positive returns for shareholders in recent times and should be considered when making investment decisions. As an investor, it's vitally important to carefully consider each company's financial performance and prospects before making any definitive judgments on potential investments.

More news about SNDL Inc. (SNDL).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Enterprise AI's Trust Gap: Microsoft-Mistral Ecosystem Expansion Meets a Governance Deficit in Agentic Adoption
Microsoft is deepening its AI platform bet through simultaneous moves — expanding its Mistral partnership (Copilot Studio, Foundry, European infrastructure capacity) and deepening enterprise AI governance ties with Manulife — just as independent research (Google Cloud, VentureBeat, Box) shows enterprises racing toward agentic AI adoption (100% planned within two years) while data access and trust in agent decisions lag badly (average 45% data access, only ~half trust agent outputs). The result is a structural mismatch between platform-vendor momentum and enterprise readiness to actually govern and trust the agents being deployed.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Morgan Stanley & Co. LLC
Same entity (Morgan Stanley & Co. LLC), same metric (net_income), same fiscal period (Q1 2026), same observation date (2026-03-31), but vastly different values: $5.567 billion vs. $5.57. These cannot coexist for the same time period. Fact B appears to be a data entry error (possible missing decimal placement: 5.57 should likely be 5,567,000,000 or a per-share figure incorrectly entered as total).
We flag conflicts openly ›
Recently verified
Checked against the original source
4,979
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,979 facts checked against source5,257 source documents archived
Query this data → isubstrate.com